Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07JFY
|
|||
| Drug Name |
PMID29473428-Compound-43
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
REDX PHARMA PLC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H13BrClN3O
|
|||
| Canonical SMILES |
C1=CC(=C(C=C1Br)Cl)C(CC2C3=C(C=NC=C3)C4=CN=CN24)O
|
|||
| InChI |
1S/C17H13BrClN3O/c18-10-1-2-12(14(19)5-10)17(23)6-15-11-3-4-20-7-13(11)16-8-21-9-22(15)16/h1-5,7-9,15,17,23H,6H2
|
|||
| InChIKey |
FULOIPPDAZMZJS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target's Patent Info | [1] | |
| BioCyc | Superpathway of tryptophan utilization | |||
| Tryptophan degradation | ||||
| L-kynurenine degradation | ||||
| Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | ||||
| NAD de novo biosynthesis | ||||
| KEGG Pathway | Tryptophan metabolism | |||
| Metabolic pathways | ||||
| African trypanosomiasis | ||||
| NetPath Pathway | TSLP Signaling Pathway | |||
| IL5 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | ||||
| Pathwhiz Pathway | Tryptophan Metabolism | |||
| Reactome | Tryptophan catabolism | |||
| WikiPathways | Tryptophan metabolism | |||
| Metabolism of amino acids and derivatives | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.